Clinical trials
Phase 2 Acquired Immunodeficiency Syndrome trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2009 | 4 |
| 2010 | 2 |
| 2011 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 2 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Terminated | 3 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| ViiV Healthcare | 5 |
| ANRS, Emerging Infectious Diseases | 2 |
| GlaxoSmithKline | 2 |
| French National Agency for Research on AIDS and Viral Hepatitis | 1 |
| Intergroupe Francophone de Cancerologie Thoracique | 1 |
| Janssen R&D Ireland | 1 |
| Janssen-Cilag International NV | 1 |
| Nantes University Hospital | 1 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 1 |
| Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Acquired Immunodeficiency Syndrome | 18 |
| HIV Infections | 10 |
| Infections | 6 |
| AIDS-Related Opportunistic Infections | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Hepatitis B | 1 |
| Immunologic Deficiency Syndromes | 1 |
| Pneumonia, Pneumocystis | 1 |
| Retroviridae Infections | 1 |
| Sexually Transmitted Diseases | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.